NCT04697628 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04697628
Title	Tisotumab Vedotin vs Chemotherapy in Recurrent or Metastatic Cervical Cancer (innovaTV 301)
Acronym	innovaTV 301
Recruitment	Active, not recruiting
Gender	female
Phase	Phase III
Variant Requirements	No
Sponsors	Seagen Inc.
Indications	cervical squamous cell carcinoma cervical adenocarcinoma cervical adenosquamous carcinoma
Therapies	Topotecan Gemcitabine Irinotecan Tisotumab vedotin-tftv Pemetrexed Disodium Vinorelbine
Age Groups:	adult \| senior
Covered Countries	USA \| SWE \| POL \| NOR \| NLD \| ITA \| HUN \| GBR \| FRA \| FIN \| ESP \| DEU \| CZE \| CAN \| BRA \| BEL \| AUT \| ARG

NCT04697628
Clinical Trial Detail